A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis.
When the spinal cord is damaged, the resulting paralysis is usually considered permanent. Now, a new research approach using lab-grown organoid models suggests that it actually might be reversed.
Persistent long Covid symptoms are often linked to brain inflammation. However, results from a new study point at a different explanantion for fatigue, cognitive impairment, anxiety, and depression.
People with multiple sclerosis (MS) now live significantly longer, thanks to advances in treatments and care, a new study finds. However, inequalities remain, with higher mortality in deprived areas.
Siemens Healthineers has announced the availability of two blood-based biomarker tests for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and the Atellica IM Brain Derived Tau (BDTau) assays. Both are run on the Atellica Solution IM and Atellica CI Analyzers.
At this year’s European Congress of Radiology (ECR) in Vienna, Bayer presented new data on a contrast agent that could transform MRI imaging: gadoquatrane, which requires up to 60% less gadolinium than previous standard macrocyclic preparations whilst maintaining the same diagnostic accuracy. Prof. Hubertus Pietsch, Head of MRI & CT Contrast Agent Research at Bayer and one of the key…
The immune system’s reaction to the common Epstein-Barr virus (EBV) can ultimately damage the brain and contribute to multiple sclerosis (MS), a new study shows.
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
Philips and Cortechs.ai have extended their collaboration to integrate AI-enabled quantitative neuroimaging analytics directly into MR systems. The partnership aims to provide radiologists with automated, objective measurements of brain structures and lesions to support diagnosis and monitoring of neurological conditions.
Experts from the University of Nottingham have proven that multiple sclerosis can successfully be diagnosed using an MRI scan, meaning patients no longer need to undergo a painful lumbar puncture.
A new biomarker for multiple sclerosis: the inflammatory cell rim from microglial cells surrounding brain lesions was found to directly correlate with the severity and speed of disease progression.
Multiple sclerosis often transitions from a relapsing-remitting to secondary progressive form, which requires different treatment. Now, an AI model can determine this change with 90% certainty.
A new AI tool can extract key information from brain MRI scans of multiple sclerosis (MS) patients. This could be used to improve disease and treatment response monitoring.
A new study highlights the potential of a gamified mobile health app designed to help people with Multiple Sclerosis manage fatigue, one of the most common and debilitating symptoms of the disease.
Playing video games to recover hand and wrist mobility? A new system of exergames demonstrates the potential for rehabilitation while providing therapists with data to analyse patients’ progress.
By detecting nerve connections in the injured spinal cord, a newly developed radiotracer could help diagnose injuries more precisely, monitor recovery, and evaluate therapy effectiveness.
Can an AI predict the progression of multiple sclerosis in a patient over the subsequent months and years? Researchers in Belgium used machine learning to do just that – with promising results.
Doctors may soon have a new, high-tech way to diagnose Multiple Sclerosis using special eye scans. This could make it easier and faster for people to find out if they have MS.
Digital twin technology can transform clinical practice by aiding patient-specific prediction and supporting personalized treatment models. Expert speakers at an ECR 2024 session in Vienna focussed on how radiology will play a leading role in the advance through data acquisition via a range of imaging modalities.
In some patients with multiple sclerosis (MS), symptoms worsen during treatment, but MRI scans do not indicate any change. In such cases, positron emission tomography could help, a new study suggests.
Researchers discovered three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. This opens new avenues for personalized treatment strategies.
Researchers have now shown that a noninvasive treatment that stimulates gamma frequency brain waves may hold promise for treating memory impairment and other cognitive effects of chemotherapy.
The loss of myelin sheaths in the brain is a hallmark of multiple sclerosis. Swiss researchers have now developed an MRI method that maps the condition of this nerve insulation layer more accurately.
MEDICA trade fair (Nov 13-16, Düsseldorf) is a major event for start-ups entering the health sector. Hundreds of young developers seek business contacts for cooperation concerning funding, production, approval, marketing or sales of their products.
The 2023 AACC meeting saw two exciting AI applications in lab medicine: a predictive algorithm for MS, and machine learning for detecting contaminated lab samples.
Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy treatment that re-engineers a patient’s own T-cells to help them attack malignant tumour cells. It has been very effective in the treatment of blood cancers, including certain types of leukaemia and lymphoma. However, two serious side effects are common as a result of the treatment: cytokine release syndrome (CRS) and immune…
Women suffering from multiple sclerosis temporarily get much better when pregnant. Researchers have now identified the beneficial changes naturally occurring during pregnancy.
Researchers at Karolinska Institutet have found further evidence for how the Epstein-Barr virus (EBV) can trigger multiple sclerosis (MS) or drive disease progression.
Doctors across all disciplines, with assistance from artificial intelligence, may soon have the ability to quickly consult a patient's entire medical file against the backdrop of all medical health care data and every published piece of medical literature online.
Multiple sclerosis affects three women for every one man. French scientists are studying the role of the sex hormones in order to better understand this discrepancy.
Researchers from the US, Singapore and Geneva have developed a novel combination therapy using an anticancer agent for treating vancomycin-resistant Enterococcus faecalis (VRE).
Findings of bacteria with anti-inflammatory effects in the intestines of MS patients with no evidence of active disease indicate that diet, bacteria and disease progression are linked.
Are climate change and air pollution making neurologic diseases like headaches, dementia and multiple sclerosis (MS) worse? A scoping review of research explores the connection.
Siemens Healthineers presented its latest magnetic resonance tomographs designed for clinical and scientific use at the company's Shape 23 Keynote: The 3T Magnetom Cima.X and 7T Magnetom Terra.X.
Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study examined how the treatment curbs the disease and how the immune system regenerates afterwards.
Researchers mapped in detail how the immune system acts against pathogens invading the brain. This sheds new light on host-pathogen interactions and the long-term consequences of brain infections.
US researchers have developed a test to detect loss of myelin - a key contributor to many neurological diseases including multiple sclerosis, traumatic brain and spinal cord injuries, stroke, and dementia.
A large epidemiological study shows that patients with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease than individuals without autoimmune disease.
Researchers visualize brain inflammation using diffusion-weighted MRI. This detailed "X-ray" of inflammation cannot be obtained with conventional MRI, but requires data acquisition sequences and special mathematical models.
Cerebral white matter hyperintensities (WMH) can have a devastating impact on a patient’s life. Radiologists must learn to recognise these white spots in the brain and conventional imaging may just reveal the tip of the iceberg.
Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA, Würzburg researchers discovered.
Cedars-Sinai physician-scientists are pioneering imaging techniques and investigating new biomarkers to improve multiple sclerosis (MS) diagnosis and treatment.
Scientists have developed a neutron-based method to study brain slices and gain a better understanding of neurological diseases.
Pre-transplant chemotherapy facilitates the replacement of the brain's innate immune cells, by other immune cells derived from the transplanted stem cells.
Nerve damage in multiple sclerosis can be detected via the concentration of neurofilament light chain in the blood. This could offer valuable information on future disease course and therapy effectiveness.
Cleveland Clinic has launched a landmark study to better understand why millions of people around the world suffer from brain diseases, with the goal of pinpointing disease biomarkers early, well before clinical symptoms present themselves.
A connection between the Epstein-Barr virus and multiple sclerosis has long been suspected. A new study provides ‘compelling evidence of causality’.
Researchers outline a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms and whether these cancers have metastasised in the body.
In the fight against diseases like amyotrophic lateral sclerosis (ALS), biomedical engineering researchers at the University of Southern California have created a powerful lab model to better see how our muscles and neurons connect.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study. ALS is the commonest form of motor neuron disease - a progressive nervous system disease that destroys nerve cells responsible for voluntary movement such as walking and talking.
Scientists are using artificial intelligence (AI) and the Cambridge-1 supercomputer to synthesise artificial 3-D MRI images of human brains and create models that show disease states across various ages and genders. The Synthetic Brain Project is focused on building deep learning models which have been developed by King’s College London (KCL) and NVIDIA data scientists and engineers as part of…
Tiny 3D models that mimic vital aspects of the human nervous system have been developed in a step that could accelerate drug research for neurological conditions such as multiple sclerosis (MS). The millimetre-wide models – created using stem cells from human skin samples – will be used to study myelin, an insulating substance that helps nerve cells communicate with each other. Researchers…
Researchers have discovered that microglia cells constantly survey the brain to prevent spontaneous seizures.
At Fraunhofer IZM, research is being conducted on durable microimplants that stimulate nerve cells electrically in a targeted manner and are even to be used to treat multiple sclerosis. Read more in the MEDICA magazine.
The Focused Ultrasound Foundation (FUS) has published its 2020 State of the Field Report, a 63-page annual update detailing new potential indications, laboratory research, clinical trials, treatments and growth in worldwide procedures performed in 2019.
An up-and-coming gene therapy for blood disorders. A new class of medications for cystic fibrosis. Increased access to telemedicine. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of clinicians and researchers from Cleveland Clinic. In conjunction with the 2020 Medical Innovation Summit, Cleveland Clinic…
Value-based healthcare is gaining momentum and radiologists must increasingly show their contribution in improving patient care. Artificial intelligence (AI) can help them to do so and brings a series of new opportunities, according to Charles E Kahn, Professor and Vice Chairman of Radiology at the University of Pennsylvania, speaking at a meeting in Madrid in January. AI can do a lot to improve…
Random Walk Imaging AB (RWI), a company developing novel software solutions for diffusion magnetic resonance imaging (MRI), announced the launch of its first commercial software product for clinical researchers and radiologists. The dViewr Powered by Mice Toolkit is the result of a collaboration with Nonpi Medical AB, with whom RWI has entered into an exclusive license and development agreement…
This year’s ”MS Experts Summit” sees 18 clinicians and researchers convene online for seven sessions during this summer. Under the motto “People with MS: 360º evidence-based daily management” international speakers with expertise in various domains of multiple sclerosis (MS) exchange their latest advances in managing patients suffering from this disease. In his talk “MRI imaging in…
Random Walk Imaging (RWI), a company developing novel software solutions for magnetic resonance imaging (MRI), announced positive data from a study in multiple sclerosis (MS) patients using its proprietary scanning method and software protocol. Data from the study, which was conducted at the Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, demonstrated a…
As Covid-19 spreads throughout the country, much attention has been paid to the devastating effects of the virus on the lungs. But doctors are learning how the virus may affect other organs, including the brain. Some patients with Covid-19 have had neurological symptoms, which may include an increased risk of stroke.
Re-using clinical data for research is an academic and organisational challenge, but there is much to gain from this to advance healthcare. During the January Triangle leadership meeting in Madrid, Dr Xavier Pastor, CMIO at Hospital Clínic – Universitat de Barcelona, explained how his institution developed one of Spain’s first programs to promote real world data use in research projects.…
Magnetic resonance imaging (MRI) usually measures the magnetic moment of the hydrogen atomic nuclei arising from the spin. However, scientists at the German Cancer Research Centre (DKFZ) are investigating the spin of other nuclei for imaging: ‘X-nuclei imaging has a large potential for MRI imaging as the x-nuclei play an important part in many physiological processes,’ according to doctor and…
People with multiple sclerosis (MS) who also have depression are more likely to suffer debilitating symptoms early than people with MS who are not depressed, according to a study at Karolinska Institutet in Sweden that is published in the journal Neurology. The findings highlight the need for early recognition and treatment of depressive symptoms in patients with MS. More than 2 million people…
New simulation technology developed by TU Graz is designed to make the production of biopharmaceuticals more efficient, cost-effective and comprehensible for manufacturers.
The World Health Organisation's (WHO) Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. Now, updated versions of the two lists have been published, focusing on cancer and other global health challenges, with an emphasis on effective…
New results of a 65-year follow-up study of nearly 7,000 Norwegian patients with Multiple Sclerosis (MS) suggest that patients may have a greater overall risk of developing cancer than the general population, with an especially high risk of cancer in respiratory organs, urinary organs and the central nervous system. Presented at the 5th European Academy of Neurology (EAN) Congress in Oslo,…
We all know someone affected by the battle against cancer. And we know that treatments can be quite efficient at shrinking the tumor but too often, they can’t kill all the cells, and so it may come back. With some aggressive types of cancer, the problem is so great that there is very little that can be done for the patients.
A new vaccination for malignant astrocytoma brings such patients hope. However, research is still in its infancy. We spoke with Professor Michael Platten, Medical Director of the Neurological Clinic at Medical University Mannheim, about the present state of research and the serious opportunities this presents. During the interview, he also revealed how cooperation with the pharmaceutical industry…
Artificial intelligence clinics and rehab bikes, exoskeletons and stylish protections masks – healthcare in Taiwan has many faces and facets as the international medical & healthcare exhibition Medical Taiwan in Taipei will show from 27 to 30 June 2019. We visited participating companies and hospitals to give you a sneak preview of some of the highlights that might well create a buzz in…
A recently recognized brain disorder that mimics clinical features of Alzheimer’s disease has for the first time been defined with recommended diagnostic criteria and other guidelines for advancing and catalyzing future research. Scientists from several National Institutes of Health-funded institutions, in collaboration with international peers, described the newly-named pathway to dementia,…
The speed of the human brain is remarkable. Almost immediately upon being exposed to stimuli, neurons are activated, prompting subconscious reactions and, a fraction of a second later, thought. But the speed at which we can noninvasively follow brain function using an MRI is not as impressive. Functional MRI (fMRI), which measures changes in blood-oxygen levels, has revolutionized neuroscience by…
Some studies have suggested that minerals such as zinc and iron may play a role in how multiple sclerosis (MS) progresses, once people have been diagnosed with it. But little was known about whether zinc, iron and other minerals play a role in the development of the disease. A new study shows no link between dietary intake of several minerals and whether people later develop MS. The study is…
Neurological complications due to infections with (novel) enteroviruses are rarely the focus of medical research. Thus, an article published in the German medical journal Der Nervenarzt (published at the Medizinische Hochschule Hanover (MHH) – has created quite a stir. We spoke with one of the authors, Professor Martin Stangel, about current clinical practice in terms of enterovirus.…
Ultra-high-field magnetic resonance tomography with field strength of 7 Tesla is slowly but surely entering clinical routine. ‘Thanks to very high spatial and spectral resolution, ultra-high-field MR permits detailed views of the human anatomy and can show precisely the metabolic processes such as those in the brain,’ said Professor Siegfried Trattnig, from Vienna’s Medical University.
White matter on the brain is a difficult subject. Even the terminology is varied, making differential diagnosis complex. An understanding of prevalence and of the tools available to facilitate the diagnosis of individual diseases is important, Dr Gunther Fesl, radiologist at Praxis Radiologie Augsburg, explains.
A new study shows that there is a very limited regeneration of cells in the brain of patients diagnosed with multiple sclerosis (MS). These findings underline the importance of treating MS at an early stage of the disease progression, when the affected cells can repair the damage as they are not replaced by new ones. The results are published in the journal Nature by researchers from Karolinska…
MRI has developed rapidly over the past decade in Poland, where clinicians are combining MRI with PET and CT to highlight tumour growth or regression and perfusion. ‘The fact that MRI offers new software and programmes means we can diagnose pathologies more precisely and make a diagnosis faster than a few years ago,’ explained Poland’s national advisor on radiology and diagnostic imaging…
The way you walk can reveal current and future health problems. New research from Halmstad University suggests the use of wearable sensors for analysing your movement. This can potentially result in early detection of for example Parkinson’s disease, dementia, multiple sclerosis and other neuro-physiological disorders. Many of our body systems, such as the cardio-vascular system and the…
A far-reaching study conducted by scientists at Cincinnati Children’s reports that the Epstein-Barr virus (EBV)—best known for causing mononucleosis—also increases the risks for some people of developing seven other major diseases.
Gadolinium-containing/gadolinium-based contrast agents (GCCAs/GBCAs) and their usage was a major topic at ECR 2018. Fuelled by the current debate a number of presentations focused on possible impact, risks and necessities. Some were highly specific, others took a broader view. The only consensus, however, seems to be the need for more research and the focus on safety. Three ECR speakers, Joseph…
Eating fish at least once a week or eating fish one to three times per month in addition to taking daily fish oil supplements may be associated with a reduced risk of multiple sclerosis (MS), according to a preliminary study that will be presented at the American Academy of Neurology’s 70th Annual Meeting in Los Angeles, April 21 to 27, 2018. These findings suggest that the omega-3 fatty acids…
The immune system is a complex and precisely regulated system. Various activating and inhibiting signals ensure that the immune cells combat pathogenic agents without eliciting a potentially harmful response to its own structures and cells. However, if those two forces are imbalanced, the immune cells may attack and damage cells and tissue of the body itself, which will result in the development…
A new method of drug manufacture which uses 3D printers to create pharmaceuticals on demand could lead to a ‘Spotify for chemistry’, scientists claim. In a new paper published in the journal Science, researchers from the University of Glasgow present for the first time a new approach to the manufacture of pharmaceuticals which can be made using a digital code. This code is used by a 3D…
Gene expression in specific cells and in specific regions can provide a more precise, neuroprotective approach than traditional treatments for neurological diseases. For multiple sclerosis, specifically, increasing cholesterol synthesis gene expression in astrocytes of the spinal cord can be a pathway to repair nerves that affect walking.
The Russian biotechnology company Biocad plans to enter the European market with oncological and autoimmune medicines. So far, there are seven molecules in the European portfolio of Biocad. The biosimilar products could be used in treatment of melanoma, breast, stomach, kidney and lung cancer, rheumatoid arthritis, psoriasis and multiple sclerosis.
Researchers have evidence that specialized T cells are vulnerable to exhaustion that may contribute to allergic reactions.
Although dementia is most often seen in adults, childhood or adolescent dementia does occur. A team of researchers from the University of Würzburg believes that established therapeutic drugs might be effective against childhood dementia.
The Congress of the European Academy of Neurology (EAN) in Amsterdam received a royal visit: H.M. Queen Máxima of the Netherlands attended the major scientific event at RAI Amsterdam, in which over 6,000 people are participating.
Positron Emission Tomography (PET) is helping to provide MS experts some insight into what drives progression of the disease. PET also has the potential to quantify the effects of new, targeted therapies on MS patients, according to consultant neurologist Professor Bruno Stankoff.
What if a single smartphone app could help solve the enigma of multiple sclerosis (MS) and move new treatments ahead at lightning speed? That was the bold idea that led Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world’s first smartphone app capable of…
Spanish researchers are challenging the validity of many past and ongoing clinical trials and stress the importance of working with raw or preprocessed data in genetic information study.
Over the next few years, in a research project funded by the EU, an international consortium is developing a new technology for a better treatment of multiple sclerosis. The idea of the innovative “Nose2Brain” approach is to transport a special active substance directly through the nose into the central nervous system.
A simple eye test could help solve the biggest global cause of irreversible blindness, glaucoma. In clinical trials, the pioneering diagnostic test - developed by researchers at UCL Institute of Ophthalmology and the Western Eye Hospital - allowed doctors to see individual nerve cell death in the back of the eye.
The Technion breathalyzer would give pathology groups and medical laboratories unprecedented ability to support physicians in diagnosing and treating cancers, chronic diseases, and other illnesses.
Project will explore quantitative MRI metrics for more informed treatment decision making
Genetics stepping ahead as Spain-based researchers develop biomedical robots that can help in the study of rare diseases, neurodegenerative disorders and cancer, as well as the creation of orphan drugs.
An international team of 56 researchers in five countries has confirmed a hypothesis first proposed by the ancient Greeks – that different diseases are characterized by different “chemical signatures” identifiable in breath samples. The findings by the team led by Professor Hossam Haick of the Technion-Israel Institute of Technology Department of Chemical Engineering and Russell Berrie…
The 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis opened in London (September 14-17) and key presentations reveal the latest evidence-based thinking on how to use MRI scan results to diagnose MS with increasing accuracy. Earlier this year, MAGNIMS, the European Collaborative Research Network that studies the use of MRI when diagnosing MS, published…
From the beginning of MRI scientists dreamed of not only translating data sets into images, but also classifying tissue directly. Five years ago this would still have been inconceivable.
Stroke patients will first undergo a CT scan as they enter the hospital. Before any further imaging scan is carried out, the medical team must decide whether they need to intervene intra or extra cranially. ‘Imaging enables you to see which pathology you are dealing with and helps you select patients for either recanalisation or revascularisation or, in some cases, occlusion by embolisation,’…
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Scientists at the University of British Columbia and Vancouver Coastal Health have proven that multiple sclerosis (MS) can be caused by a single genetic mutation – a rare alteration in DNA that makes it very likely a person will develop the more devastating form of the neurological disease.
Her Majesty Queen Elizabeth II has officially opened the Cardiff University Brain Research Imaging Centre (CUBRIC), a unique neuroimaging research hub in Wales. The facility will seek to provide unprecedented insights into the causes of neurological and psychiatric conditions such as dementia, schizophrenia and multiple sclerosis, as well as an understanding into the mechanisms of a healthy…
Scientists from the universities in Münster and Munich have discovered what precisely goes wrong in the body in the case of multiple sclerosis (MS). At the same time the neuroscientists were able to demonstrate that for MS, which occurs in bouts, there is a therapy which is tailor-made to eliminate the deficit.
The Zika virus may be associated with an autoimmune disorder that attacks the brain's myelin similar to multiple sclerosis, according to a small study that is being released today and will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.
A research team headed by scientists at the Institute of Neuroimmunology and the Institute for Multiple Sclerosis Research (IMSF), University Medical Center Göttingen (UMG), has gained new insights into the immune function of cerebrospinal fluid (CSF). They used real-time microscopy to film the lively trafficking of immune cells between the CSF and the nervous tissue. Here the meninges play the…
A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The University of Nottingham and Nottingham University Hospitals NHS Trust.
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surprising new view of the disease reported in a study from Northwestern Medicine and The University of Chicago.
Patients with multiple sclerosis often receive a "hit and miss" treatment when the disease breaks out. A blood analysis is now for the first time able to reveal which of the two most important first-line drugs is better suited for which patients.
A number of innovative research results were presented at the 24th Congress of the European Academy of Dermatology and Venereology that took place in Copenhagen from 7 to 11 October 2015. Some of these results are expected to impact medicine far beyond dermatology, demonstrating the innovative character of the specialty.
Linköping University Hospital in Sweden installs SyMRI NEURO from SyntheticMR in order to improve the follow-up of patients with Multiple Sclerosis (MS). SyMRI enables objective follow-up of brain atrophy through automatic calculation of Brain Parenchymal Fraction (BPF). After an initial pilot project, the aim is to take SyMRI into clinical use in Region Östergötland during 2016.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that people with systemic sclerosis (SSc) have a unique bacterial signature in their colon, when compared with healthy people.
Manuela Messmer-Wullen awoke in her hotel room one morning, during a business trip, and realised she was hemiplegic. There were also cognitive impairments and she could not articulate. Diagnosis: Stroke. ‘In the very first period after the stroke, contact with radiologists was very strange and mysterious for me.’ Report: Michael Krassnitzer
Black Blood Imaging may not sound helpful – but it is. The MRI specialist can work with clearer contrasts and gain greater certainty in tumour diagnosis as well as the detection of inflammatory changes in tissue.
Earlier this year a drug was launched that can cure hepatitis C without severe side effects in most patients. Whilst the treatment is fast, it is very expensive but does avoid liver cancer and thus makes liver transplants superfluous. This is only one of the many promising developments in hepatitis research that Dr Markus Cornberg of the Medical University Hanover will address at the Medica…
Radiology will be in the spotlight on November 8, as radiologists celebrate the International Day of Radiology (IDoR) through a series of events and information campaigns to help the public better understand the role of medical imaging in healthcare.
The numbers of ‘suicide tourists’ going to Switzerland to take their own lives has doubled within the space of four years, reports a study published online in the Journal of Medical Ethics.
European Hospital met up with Professor Harald H. Quick, PhD, who was appointed Director of the Erwin L. Hahn Institute (ELH) for Magnetic Resonance (MR) Imaging this February.
For the first time, the right of patients in Europe to seek healthcare in another Member State, and be reimbursed for it, is clearly established thanks to the EU Directive on Patients’ Rights in Cross-Border Healthcare. EPF organised a three-day regional conference to enable Patient leaders to understand the details of this legislation and its transposition at national level.
Multiple sclerosis (MS) – the inflammatory condition in the central nervous system (CNS) – leads to scarring, with several scars forming lesions, also called plaques. Although long assumed that only white matter is involved, this is increasingly questioned.
There are too many loopholes that allow bad or fraudulent physicians to beat the system.
EH Paris correspondent Annick Chapoy, reports on a French study that confirms the relevance of a drug with a long history in the management of other diseases
Controversies were certainly aired when 800 radiologists gathered in Salzburg for The Interventional Radiological Olbert Symposium - a meeting of the German, Austrian and Swiss Societies for Interventional Radiology (DEGIR ÖGIR and SGCVIR) – and certainly some striking new interventions were presented. Michael Krassnitzer reports
Silicone breast implants are the most popular type of implant. The postulated relation between silicone breast implants and the risk of connective tissue and autoimmune diseases has generated intense medical and legal interest during the past decade. Considerable controversy has surrounded the long-term safety of silicone breast implants.
We may be able to live longer due to medical advances, but what of the ability to live independently in old age? According to DeStatis, the German Federal Statistical Office, by 2050 there will be a deficit of 260,000 caregivers – and Germany is not alone in this.
Researchers from London's Kingston University have developed a new highly-accurate blood test which can detect how much a patient's diet could be responsible for a lack of the so-called "sunshine vitamin". Vitamin D deficiencies can weaken the immune system and increase the risk of cancer and osteoporosis.
A nice drink cannot do any harm? Brain says no. A new study by a Chinese research group shows that even low doses of alcohol can harm the brain immediately though not permanently. “We were investigating the acute effects of low and high doses of alcohol by diffusion tensor imaging, wondering whether the consequences of alcohol administration can be observed by the measurement of apparent…
Biomarkers – mainly defined as surrogates serving as indicators for specific biological states – play an ever-increasing role in neuroscience and especially in the management of multiple sclerosis, scientists reported today at the 21st Meeting of the European Neurological Society (ENS) in Lisbon. In analyzing gene expression patterns, immunological changes and imaging abnormalities,…
The IMS Institute for Healthcare Informatics today reported that global spending for medicines will reach nearly $1.1 trillion by 2015, reflecting a slowing compound annual growth rate of 3-6 percent over the next five years. This compares with 6.2 percent annual growth over the past five years.
The Netherlands - In a very crowded train station, why can you immediately recognise the face of a friend? Professor Rainer Goebel wants to find out. Thanks to €10 million in funding from the country’s Limburg Province, the Brains Unlimited project at Maastricht University will install three high-field magnetic resonance imaging scanners that will allow Prof. Goebel to search for an…
It’s a war against a perceived enemy that is not – autoimmune disease like rheumatoid arthritis, lupus erythematosus or multiple sclerosis, occur when the immune system attacks normal tissue components. Characteristic of those disease patterns are autoantibodies in the blood, which the immune system produces to attack its own organism.
MS experts, European policy-makers, professional and patients’ organisations at the European Health Forum Gastein (EHFG) today called for benchmark care provision across the EU and for governments and health services to provide improved access to specialized care for patients with multiple sclerosis. About 600 decision makers in the fields of health policy, research, science and from…
A multiple sclerosis risk sharing scheme, set up by the Department of Health (DoH) in 2002 to ensure that disease-modifying drugs were available on the National Health Service (NHS), has been deemed ‘a costly failure’, according to researchers reporting on www.bmj.com in June. The scheme, they advise, should not be continued.
The first major survey of European Multiple Sclerosis (MS) nurses revealed that nearly one in three nurses (31%) reported that standards of MS care are not adequately maintained in their country. The results of this survey will be presented for the first time on Friday 28 May, via a live webcast at the European MS Platform (EMSP) Annual Congress in Stuttgart, Germany.
2010 workshop in Aachen, Germany, in March, were welcomed by Professor Thomas M Deserno, head of the Medical Informatics Department at RWTH Aachen University and organiser of what turned out to be an ‘outstanding’ scientific programme.
More than 2 million over the world suffer from Multiple sclerosis (MS). It attacks the central nervous system and eventually renders most patients disabled. Although there is currently no cure, a breakthrough finding from a Tel Aviv University scientist and physician may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease.
The Royal College of Nursing (RCN) has joined forces with almost 40 of the UK's leading health organisations to warn that cutting specialist nurse services for people with long term conditions would be a "false economy", as they began a campaign for guaranteed access to specialist nursing care for all patients with long term conditions.
Most of the 30 institutes around the world that work with a 7-Tesla MRI scanner do not focus on answering questions about the clinical benefit of this field strength; their efforts revolve around the brain and neurosciences. One exception is the Erwin L Hahn, at the Institute for Magnetic Resonance Imaging, which is based at the Zollverein Coal Mine Industrial Complex, a World Heritage Site in…
Europe holds a leading position in the research and development of MRI, which has been used for over 25 years, imaging up to 500 million patients without evidence of harm to workers due to EMF exposure. It is also well known that MRI is free from health risks associated with ionising radiation such as X-rays, in many situations the alternative to MRI
The inflammatory process in the brain of multiple sclerosis patients is triggered by their own immune system. However, there is one type of immune cells that seems to fight against the destructive progress - and might be used for therapeutic purposes in future.
In a symposium organised by Bayer Schering Pharma at the 2009 European Congress of Radiology (ECR), the audience heard a series of four presentations on the potential advantages of high-signal-intensity contrast agents for MRI, focusing on gadobutrol (Gadovist). During the discussion, several claims made by the speakers were challenged and debated by ECR delegates.
The clear focus of the numerous lectures given at the International MRI Symposium was on cardiac imaging.
Irish and German neurology associations warn of an imminent shortage of neurologists. In Ireland, according to experts the situation is “lacking at best” and “catastrophic at worst”. German physicians as well detect increasing deficiencies in neurological care coverage primarily due to an aging population and concomitant morbidity.
CMIV has a new patent-pending technology that is set to radically change the way and speed at which radiologists work. The system could produce earlier diagnoses of certain disease, according to scientist Anders Persson MD PhD, Director and Member of the Board of the Centre for Medical Imaging Science and Visualisation (CMIV), at Linköping University, Sweden. CMIV has worked in close cooperation…
Thanks to a new software, MR images from a five-minute scan may generate the images for a complete and comprehensive examination and therefore eliminating the need to perform multiple scans. The advanced software developed by Synthetic MR AB will be offered as a clinical application in Sectra´s PACS system.
Where are the most high-tech start-ups? That`s an easy one: Silicon Valley. But who comes in a close second? Surprisingly: Israel. Further: Israel ranks Number 1 in terms of availability of scientists and engineers and Number 2 in quality of higher education. The result of this impressive track record is a wide range of successful enterprises and products, particularly related to the life…
Surgery in the lower pelvic region often involves injury to or severing of nerve tissue. As in chronic diseases of the nervous system, the result can be pain, sensory disturbances or loss of function. Up to now the poor view of the nerves, partially formed of fine interwoven networks, has been one of the major problems – exacerbated by the strict division of skills between neurologists and…
The Virtual Institute for Seven Tesla Applications (VISTA) is a partnership of several Dutch universities. To evaluate the benefit of ultrahigh-field MRI the first human 7.0T whole-body research scanner, supplied by Philips Medical Systems, was installed at the Leiden University Medical Center (LUMC). Roland Plasterk, the Durch minister of education, culture and science, attended at the opening…
Scientists from the italian Fondazione Santa Lucia in Rome and the german Max Delbrück Center for Molecular Medicine in Berlin recently discovered a correlation between the number of a subgroup of regulatory T-cells and Multiple Sclerosis, that perhaps may lead to new treatment options.
Mastering the “uncontrollable beast” By Brenda Marsh, Editor, European Hospital.
The value of diffusion-weighted and diffusion tensor imaging techniques.
The foundation of the AESKU.KIPP Institute, based in Wendelsheim, Germany, presents a platform to initiate and co-ordinate international auto-immunity research projects.
Researchers open up new opportunities for cellular and molecular MR imaging.
Many different forms, unclear origins: Multiple sclerosis (MS) is one of the most common neurological diseases that often leads to disability in those affected. Read more about current research and therapeutic approaches to MS.
Neural networks are emblematic of complex systems, so it's no surprise that the field of neurology is eclectic and intricate, too. Main challenges for neurologists are therapies of and research on stroke, seizures, movement disorders such as Parkinson's disease, autoimmune disorders such as multiple sclerosis and dementias such as Alzheimer's disease.
